WeWork Working Toward IPO, Valisure Says Carcinogen Found in Zantac, Investing in Global Disruption
Bloomberg Senior Reporter Gillian Tan and David Snider, CEO of Harness Wealth, discuss Wework going forward on their IPO with governance changes. Paul Rabil, Co-Founder a Chief Strategy Officer Major League Lacrosse, shares a recap of the debut season of the league and takes a look at their innovative postseason format. Bloomberg Business of Sports Host Scott Soshnick also participates in the discussion with Paul. Bloomberg News Health Policy Reporter Anna Edney and David Light, CEO at Valisure, talk about the discovery of a carcinogen in the stomach medication Zantac and generics. Eric Martineau-Fortin, Founder of White Star Capital, discusses investing in emerging and disrupting companies around the globe. And we Drive to the Close with Bill Page, Senior Portfolio Manager at Essex Investment Management. Hosts: Carol Massar and Jason Kelly. Producer: Paul Brennan.